Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucozide-M Tablet

Prescription Icon
Prescription Required

Marketer

Veecube Healthcare Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glucozide-M Tablet

DiaBeta-Duo tablets are classified as antidiabetic medications, combining two active components for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. DiaBeta-Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. DiaBeta-Duo is only one element of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods, juice) is crucial to manage hypoglycemia. Regular meals are essential, and carrying a fast-acting glucose source is recommended. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to evaluate blood cell counts and liver function, are recommended by your doctor.

Primary Ingredients of Glucozide-M Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glucozide-M Tablet

Diabetes mellitus type 2

Major Benefits of Glucozide-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glucozide-M Tablet with a meal.

Common Side effects of Glucozide-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glucozide-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glucozide-M Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Glucozide-M Tablet works:

Glucozide-M tablets contain gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glucozide-M Tablet ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Taking Glucozide-M tablets during pregnancy is unsafe due to established risks to the fetus. A physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glucozide-M tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glucozide-M Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glucozide-M Tablet use. Physician consultation is essential. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucozide-M tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Glucozide-M; in mild to moderate cases, initiate treatment with a reduced dose. Physician consultation is advised.

What if you forget to take Glucozide-M Tablet :

Should you forget a Glucozide-M Tablet dose, administer it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glucozide-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glucozide-M Tablet

Glucozide-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Glucozide-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Glucozide-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glucozide-M Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is best avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glucozide-M and seek immediate medical attention.
Prolonged Glucozide-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended annually, according to some research.
Glucozide-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glucozide-M tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glucozide-M Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glucozide-M Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glucozide-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glucozide-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is best avoided by patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Glucozide-M and seek immediate medical attention.
Prolonged Glucozide-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Glucozide-M Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Glucozide-M tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glucozide-M Tablet
71
MRP 82
13% off